Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Relatlimab
Trade Name
Synonyms BMS-986016
Drug Descriptions

Relatlimab (BMS-986016) is a monoclonal antibody that targets LAG3 and inhibits binding of MHC II molecules to increase cytokine production by T-cells and prevent tumor growth (Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 9520-9520).

DrugClasses Immune Checkpoint Inhibitor 148 LAG3 Antibody 18
CAS Registry Number 1673516-98-7
NCIT ID C111999

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Azacitidine + Nivolumab + Relatlimab Azacitidine Nivolumab Relatlimab 0 1
Bevacizumab + Nivolumab + Relatlimab Bevacizumab Nivolumab Relatlimab 0 1
Capecitabine + Nivolumab + Oxaliplatin + Relatlimab Capecitabine Nivolumab Oxaliplatin Relatlimab 0 1
Carboplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium + Relatlimab Carboplatin Nab-paclitaxel Nivolumab Pemetrexed Disodium Relatlimab 0 1
Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Relatlimab Carboplatin Nivolumab Paclitaxel Pemetrexed Disodium Relatlimab 0 1
Cisplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium + Relatlimab Cisplatin Nab-paclitaxel Nivolumab Pemetrexed Disodium Relatlimab 0 1
Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Relatlimab Cisplatin Nivolumab Paclitaxel Pemetrexed Disodium Relatlimab 0 1
Dexamethasone + Pomalidomide + Relatlimab Dexamethasone Pomalidomide Relatlimab 0 1
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Relatlimab Fluorouracil Leucovorin Nivolumab Oxaliplatin Relatlimab 0 1
Ipilimumab + Nivolumab + Relatlimab Ipilimumab Nivolumab Relatlimab 0 1
Ipilimumab + Relatlimab Ipilimumab Relatlimab 0 1
Linrodostat + Nivolumab + Relatlimab Linrodostat Nivolumab Relatlimab 0 1
Nivolumab + Oxaliplatin + Relatlimab + Tegafur-gimeracil-oteracil Potassium Nivolumab Oxaliplatin Relatlimab Tegafur-gimeracil-oteracil Potassium 0 0
Nivolumab + Paclitaxel + Relatlimab Nivolumab Paclitaxel Relatlimab 0 1
Nivolumab + Relatlimab Nivolumab Relatlimab 0 39
Nivolumab + Relatlimab + rHuPH20 Nivolumab Relatlimab rHuPH20 0 2
Nivolumab + Relatlimab + Tegafur-gimeracil-oteracil Potassium Nivolumab Relatlimab Tegafur-gimeracil-oteracil Potassium 0 1
Relatlimab Relatlimab 0 5
Relatlimab + Urelumab Relatlimab Urelumab 0 0


Additional content available in CKB BOOST